Data Mining, Data Visualization, Linux Operating system, Microsoft-Excel, Python Programming, R Programming, Simulation software, SQL, Statistical modeling
Who We Are
For more than two decades, going our own way has led to countless breakthroughs, bettering the lives of those suffering from rare genetic disease. In 1997 we were founded to make a big difference in small patient populations. Now we seek to make an even greater impact by applying the same science-driven, patient-forward approach that propelled our last 25 years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Through our unparalleled expertise in genetics and molecular biology, we will continue to develop targeted therapies that address the root cause of the conditions we seek to treat. Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The end goal has always been better lives and now we can reach more.
And the more people we reach, the more our impact can grow. We transform lives through genetic discovery.
Our Culture
Our desire to make a positive impact on our patients extends to our employees and BioMarin is committed to fostering an inclusive environment where every person feels seen, valued, and heard – so employees can thrive in all areas of their lives, in and outside of work. We seek to provide an open, flexible, and friendly work environment to empower people and to provide them with the ability to develop their long-term careers. Ultimately, we want to be an organization where people enjoy coming to work and take pride in our efforts to help patients.
SUMMARY:
The BioMarin Summer Internship Program will enable students to gain valuable experience and knowledge of the processes and systems within BioMarin, while gaining an insight into the pharmaceutical/biotech industry.
BioMarin’s Research & Development group is responsible for everything from research and discovery to post-market clinical development. Research & Development involves all bench and clinical research and the associated groups that support those endeavors. Our teams work on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with rare diseases. Come join our team and make a meaningful impact on patients’ lives. The Computational Biology team, within the Translational Genomics group focuses on the use of computational and statistical methods to improve our understanding of genetic diseases as well as therapeutic efficacy and safety.
JOB DESCRIPTION/PROJECT:
The Computational Biology Intern will work closely with scientists across the translational genomics team to develop computational and sequencing based methods to explore therapeutic targets for splicing based disorders. The project will have multiple potential directions that can be tailored to an intern’s particular skills and interests including single cell sequencing and analysis, pipeline development and machine learning. Candidates should feel welcome to share their specific interests.
Required Skills:
Desired Skills:
Qualifications/Eligibility:
Benefits of a BioMarin Internship:
In the U.S., the hiring range for this position is $21.00 to $50.00 per hour. The base pay actually offered will take into account internal equity and also may vary depending on the candidate’s geographic region, job-related knowledge, skills, and experience among other factors.
PLEASE NOTE: Absent a Medical or Religious reason that prohibits vaccinations, all our incoming employees must be vaccinated for COVID-19
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.
BioMarin Pharmaceutical Inc. is an American biotechnology company. It has offices in the USA, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). BioMarin was first to provide therapeutics for phenylketonuria (PKU).
San Rafael, CA, USA
4-6 year